Paid Clinical Trials in Ontario Canada

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Ontario

Top of Directory » All Locations » Canada » Ontario




  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene Foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy

    Conditions:   Lymphoma;   Multiple Myeloma;   Influenza A Virus, H1N1 Subtype
    Intervention:   Biological: AS03-adjuvanted H1N1 pandemic influenza vaccine
    Sponsors:   University Health Network, Toronto;   Princess Margaret Hospital, Canada
    Recruiting - verified November 2009

  • STOP Study: Effectiveness of Zyban in a Clinical Population

    Conditions:   Cigarette Smoking;   Nicotine Addiction;   Smoking Cessation
    Interventions:   Drug: bupropion HCl;   Behavioral: smoking cessation counselling
    Sponsors:   Centre for Addiction and Mental Health;   Ontario Ministry of Health Promotion
    Recruiting - verified November 2009

  • Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis

    Condition:   Ulcerative Proctitis
    Interventions:   Procedure: Proctosigmoidoscopy or colonoscopy with biopsy;   Procedure: Proctosigmoidoscopy;   Procedure: Blood collection;   Procedure: Electrocardiogram (ECG);   Drug: MAX-002;   Drug: Canasa®;   Drug: Placebo
    Sponsor:   Axcan Pharma
    Recruiting - verified November 2009

  • Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately

    Condition:   Peptic Ulcer Disease
    Interventions:   Drug: Esomeprazole/ASA Fixed Combination;   Drug: Esomeprazole;   Drug: ASA
    Sponsor:   AstraZeneca
    Not yet recruiting - verified November 2009

  • An International Randomized Trial of Trans-radial Versus Trans-femoral PCI Access Site Approach in Patients With Unstable Angina or Myocardial Infarction Managed With an Invasive Strategy

    Conditions:   Acute Coronary Syndrome;   Percutaneous Coronary Intervention
    Intervention:   Procedure: Percutaneous Coronary Intervention
    Sponsors:   Population Health Research Institute;   Co-sponsor: Sanofi-Aventis
    Recruiting - verified November 2009

  • Study on Duration of Bone Turnover Suppression Following Zoledronic Acid in Prostate Cancer

    Condition:   Prostate Cancer
    Intervention:  
    Sponsors:   University Health Network, Toronto;   Princess Margaret Hospital, Canada
    Not yet recruiting - verified November 2009

  • Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: linagliptin;   Drug: placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • In-vivo Wettability Grading and Assessment Study

    Condition:   Myopia
    Interventions:   Device: lotrafilcon B;   Device: Balafilcon A;   Device: Senofilcon A;   Device: enfilcon A
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • Nadolol for Proliferating Infantile Hemangiomas

    Condition:   Infantile Hemangioma
    Intervention:   Drug: Nadolol
    Sponsor:   The Hospital for Sick Children
    Not yet recruiting - verified November 2009

  • A Study of RO5072759 With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

    Condition:   Lymphocytic Leukemia, Chronic
    Interventions:   Drug: RO5072759;   Drug: rituximab;   Drug: chlorambucil
    Sponsors:   Hoffmann-La Roche;   Genentech
    Not yet recruiting - verified November 2009

  • A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma

    Condition:   Melanoma
    Interventions:   Drug: YM155;   Drug: Docetaxel
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified November 2009

  • Pharmacokinetics and Pharmacodynamics of ACP-001 (TransCon PEG hGH)

    Condition:   Healthy
    Interventions:   Drug: ACP-001 (TransCon PEG hGH);   Drug: ACP-001 (TransCon PEG hGH);   Drug: ACP-001 (TransCon PEG hGH);   Drug: ACP-001 (TransCon PEG hGH);   Drug: Placebo;   Drug: Human Growth Hormone
    Sponsor:   Ascendis Pharma A/S
    Active, not recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Augment™ Injectable Bone Graft Compared to Autologous Bone Graft in Foot and Ankle Fusions

    Condition:   Ankle/Hindfoot Fusion
    Interventions:   Device: Augment™ Injectable;   Procedure: Standard of care
    Sponsor:   BioMimetic Therapeutics
    Recruiting - verified November 2009

  • Autologous Cell Therapy for Female Stress Urinary Incontinence

    Condition:   Stress Urinary Incontinence Cell Therapy
    Intervention:   Biological: Autologous Muscle Derived Cells
    Sponsor:   Cook
    Not yet recruiting - verified November 2009

  • Concentrations of Maraviroc in the Semen of HIV-Infected Men

    Condition:   Maraviroc Concentrations in Semen
    Intervention:   Other: Measuring semen samples
    Sponsor:   Canadian Immunodeficiency Research Collaborative
    Recruiting - verified November 2009

  • An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease

    Conditions:   Crohn's Disease;   Inflammatory Bowel Disease
    Intervention:   Drug: AIN457
    Sponsor:   Novartis Pharmaceuticals
    Enrolling by invitation - verified November 2009

  • The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Flaxseed Compared With Placebo in Patients With Hypercholesterolemia

    Condition:   Familial or Severe Hypercholesterolemia
    Interventions:   Dietary Supplement: flaxseed;   Dietary Supplement: whole wheat flour
    Sponsor:   The Hospital for Sick Children
    Recruiting - verified November 2009

  • Limited Compression Ultrasound by Emergency Physicians to Exclude Deep Vein Thrombosis

    Condition:   Deep Vein Thrombosis
    Intervention:  
    Sponsors:   Queen's University;   The Physicians' Services Incorporated Foundation
    Not yet recruiting - verified November 2009

  • Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator (tPA)

    Condition:   Ischemic Stroke
    Intervention:   Device: NeuroFlo catheter
    Sponsor:   CoAxia
    Active, not recruiting - verified November 2009

  • Creighton Model Effectiveness, Intentions and Behaviors Assessment (CEIBA)

    Conditions:   Pregnancy;   Fertility
    Intervention:  
    Sponsors:   University of Utah;   Department of Health and Human Services
    Recruiting - verified November 2009

  • The Ventricular Catheter Placement Study: Assessment of Efficacy and Safety of an Ultrasound Guided Shunt Insertion Technique

    Condition:   Pediatric Hydrocephalus
    Intervention:  
    Sponsor:   University of Utah
    Recruiting - verified November 2009

  • A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Glycopyrronium bromide;   Drug: Placebo
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • Study to Determine if Monitoring of Labor Shortens the Time to Delivery

    Condition:   Pregnancy
    Intervention:   Device: BirthTrack
    Sponsor:   Barnev, Inc.
    Not yet recruiting - verified October 2009

  • Comparison of Different Methods for Reducing Pain From Influenza Vaccine Injections

    Conditions:   Pain;   Anxiety
    Interventions:   Drug: Liposomal lidocaine;   Drug: Vapocoolant spray;   Other: Rubbing adjacent to the injection site;   Other: Distraction
    Sponsor:   The Hospital for Sick Children
    Recruiting - verified October 2009

  • Increasing Smoking Cessation Counselling in Primary Care Using a Chronic Disease Management System

    Conditions:   Delivery of Health Care;   Smoking Cessation
    Intervention:   Other: New, improved smoking cessation management module
    Sponsors:   McMaster University;   Centre for Addiction and Mental Health
    Enrolling by invitation - verified October 2009

  • Promoting Evidence-Based Decision-Making in India: District Evaluation Study on Health

    Conditions:   Infectious Disease;   Cardiovascular Disease
    Intervention:   Behavioral: District health information package
    Sponsors:   St. Michael's Hospital, Toronto;   Canadian International Development Agency;   Lombard Insurance Global Poverty Action Lab;   St. John's Research Institute
    Active, not recruiting - verified October 2009

  • Simple Warfarin Dosing Algorithm Study

    Condition:   Warfarin Dosing
    Intervention:   Other: Algorithm
    Sponsor:   Population Health Research Institute
    Recruiting - verified November 2009

  • Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis

    Condition:   Ulcerative Colitis
    Interventions:   Drug: Asacol (mesalamine), High Dose;   Drug: Asacol (mesalamine), Low Dose
    Sponsor:   Procter and Gamble
    Recruiting - verified October 2009

  • Allo-antibodies in Pediatric Heart Transplantation

    Condition:   Heart Transplantation
    Intervention:  
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Heart, Lung, and Blood Institute (NHLBI)
    Not yet recruiting - verified October 2009

  • Nerve Localisation in Diabetic Neuropathy

    Condition:   Diabetic Neuropathy
    Interventions:   Procedure: Nerve Localization in Diabetics Having Foot Surgery under Ultrasound-Guided Ankle Blockade;   Procedure: Nerve Localization in Non-Diabetic Patients Having Foot Surgery Under Ultrasound-Guided Nerve Blockade
    Sponsor:   University Health Network, Toronto
    Not yet recruiting - verified October 2009

  • Restenosis Following Paclitaxel Eluting Balloon Angioplasty of Hemodialysis Access Stenosis

    Condition:   Renal Failure
    Intervention:   Device: Paclitaxel eluting balloon
    Sponsor:   University Health Network, Toronto
    Not yet recruiting - verified October 2009

  • Sleep Disorders Pre and Post Liver Transplantation

    Condition:   Liver Cirrhosis
    Intervention:  
    Sponsor:   University Health Network, Toronto
    Enrolling by invitation - verified October 2009

  • Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?

    Condition:   Influenza
    Interventions:   Biological: Fluviral influenza vaccine, 2009-2010;   Biological: Normal saline
    Sponsors:   Mount Sinai Hospital, Canada;   GlaxoSmithKline
    Recruiting - verified November 2009

  • Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV

    Conditions:   HIV Infections;   H1N1 Influenza
    Interventions:   Biological: Arepanrix;   Biological: Arepanrix
    Sponsors:   University of British Columbia;   Canadian Institutes of Health Research (CIHR)
    Not yet recruiting - verified October 2009

  • Oxygenation and Pulmonary Function in Morbidly Obese Patients Undergoing Bariatric Surgery

    Condition:   Morbid Obesity
    Interventions:   Device: Boussignac TM CPAP;   Device: Venturi Face Mask
    Sponsor:   University Health Network, Toronto
    Recruiting - verified October 2009

  • Oxytocin and Social Cognition in Frontotemporal Dementia

    Conditions:   Frontotemporal Dementia;   Pick's Disease
    Intervention:   Drug: intranasal oxytocin
    Sponsors:   Lawson Health Research Institute;   Alzheimer's Society London and Middlesex
    Recruiting - verified October 2009

  • Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

    Conditions:   Lymphoma;   Lymphoproliferative Disorder
    Interventions:   Other: biologic sample preservation procedure;   Other: informational intervention
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Allopurinol Combination Study

    Condition:   Gout
    Interventions:   Drug: RDEA594;   Drug: Placebo;   Drug: Allopurinol
    Sponsor:   Ardea Biosciences, Inc.
    Recruiting - verified November 2009

  • Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine

    Conditions:   Influenza;   H1N1 2009 Influenza
    Interventions:   Biological: Arepanrix, Vaxigrip 2009/2010;   Biological: Arepanrix, Vaxigrip 2009/2010
    Sponsors:   University of British Columbia;   Canadian Institutes of Health Research (CIHR)
    Not yet recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials